ZURA — Zura Bio Ltd
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2023-03-21.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ZURA
| date | signal | measured base rate |
|---|---|---|
| 2026-08-19 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-05-21 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-05-15 | Institutional holders jumped in a quarter ownership | -0.52% over 21 days · t = -0.38 · n = 1,553 not distinguishable from its control group |
| 2026-04-21 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-03-10 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-03-02 | Cluster buy: three or more insiders insider | +0.63% over 21 days · t = 1.84 · n = 3,050 not distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-02-26 | Access Industries Holdings LLC | Open-market purchase | 2.0M | 6.25 | 12.5M |
| 2026-02-26 | ACCESS INDUSTRIES MANAGEMENT, LLC | Open-market purchase | 2.0M | 6.25 | 12.5M |
| 2026-02-26 | AI Biotechnology LLC | Open-market purchase | 2.0M | 6.25 | 12.5M |
| 2026-02-26 | Blavatnik Len | Open-market purchase | 2.0M | 6.25 | 12.5M |
| 2024-11-25 | Thiara Parvinder Director | Open-market sale | 1.0M | 2.73 | 2.7M |
| 2024-09-16 | Davis Kim Chief Legal Officer | Grant or award | 1.0K | 0.00 | 0 |
| 2024-09-11 | Thiara Parvinder Director | Open-market sale | 3.8M | 2.70 | 10.3M |
| 2024-09-04 | Sidhu Someit Director | Open-market sale | 51.7K | 3.87 | 200.2K |
| 2024-09-04 | Sidhu Someit Director | Other Acquisition/Disposition | 593.1K | — | — |
| 2024-08-24 | Sidhu Someit Director | Grant or award | 722.0K | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 53.9M | 9.1M |
| Venrock Adviser, LLC | 38.3M | 6.4M |
| JPMORGAN CHASE & CO | 25.3M | 4.5M |
| GREAT POINT PARTNERS LLC | 25.1M | 4.2M |
| BRAIDWELL LP | 23.7M | 4.0M |
| Siren, L.L.C. | 22.2M | 3.7M |
| Commodore Capital LP | 19.3M | 3.2M |
| Pfizer Inc | 16.8M | 2.8M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 16.4M | 2.8M |
| Affinity Asset Advisors, LLC | 15.3M | 2.6M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Zura Bio Ltd (ZURA) filed form 8-K · 2026-08-17 · SEC EDGAR
- Zura Bio GAAP EPS of -$0.21 misses by $0.02 · 2026-08-11
- Zura Bio Ltd (ZURA) filed form 8-K · 2026-08-11 · SEC EDGAR
Ask the AI about ZURA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →